The pronounced lung lesions developing in LATY136F knock-in mice mimic human IgG4-related lung disease

Rationale Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a novel clinical disease entity characterized by an elevated serum IgG4 concentration and tumefaction or tissue infiltration by IgG4-positive plasma cells. Pathological changes are most frequently seen in the pancreas, lacrimal glands, and salivary glands, but pathological changes in the lung also exist. Linker for activation of T cell (LAT)Y136F knock-in mice show Th2-dominant immunoreactions with elevated serum IgG1 levels, corresponding to human IgG4. We have reported that LATY136F knock-in mice display several characteristic features of IgG4-RD and concluded that they constitute an appropriate model of human IgG4-RD in salivary glands, pancreas, and kidney lesions. Objectives The aim of this study is to evaluate whether lung lesions in LATY136F knock-in mice can be a model of IgG4-related lung disease. Methods Lung tissue samples from LATY136F knock-in mice (LAT) and wild-type mice (WT) were immunostained for IgG1 and obtained for pathological evaluation, and cell fractions and cytokine levels in broncho-alveolar lavage fluid (BALF) were analyzed. Results In the LAT group, IgG1-positive inflammatory cells increased starting at 4 weeks of age and peaked at 10 weeks of age. The total cell count and percentage of lymphocytes increased significantly in BALF in the LAT group compared to the WT group. In BALF, Th2-dominant cytokines and transforming growth factor-β were also increased. In the LAT group, marked inflammation around broncho-vascular bundles peaked at 10 weeks of age. After 10 weeks, fibrosis around broncho-vascular bundles and bronchiectasis were observed in LATY136F knock-in mice but not WT mice. Conclusions LATY136F knock-in mice constitute an appropriate model of lung lesions in IgG4-RD.

[1]  Y. Kamatani,et al.  IgG4-related disease in the Japanese population: a genome-wide association study. , 2019, The Lancet. Rheumatology.

[2]  S. Ichimiya,et al.  Analysis of allergic reaction in IgG4-related disease , 2019, Modern rheumatology.

[3]  J. Kira,et al.  A novel model for treatment of hypertrophic pachymeningitis , 2019, Annals of clinical and translational neurology.

[4]  K. Sekiguchi,et al.  Laminin 511 is a target antigen in autoimmune pancreatitis , 2018, Science Translational Medicine.

[5]  B. Malissen,et al.  LatY136F knock-in mouse model for human IgG4-related disease , 2018, PloS one.

[6]  M. Ehlers,et al.  Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways , 2018, Front. Immunol..

[7]  M. Kawano,et al.  New clues to the nature of immunoglobulin G4-related disease: a retrospective Japanese multicenter study of baseline clinical features of 334 cases , 2017, Arthritis Research & Therapy.

[8]  K. Kubo,et al.  Proposed diagnostic criteria for IgG4-related respiratory disease. , 2016, Respiratory investigation.

[9]  J. Stone,et al.  Diagnostic Approach to the Complexity of IgG4-Related Disease. , 2015, Mayo Clinic proceedings.

[10]  Y. Kawabata,et al.  Immunoglobulin G4‐related lung disease: Clinicoradiological and pathological features , 2013, Respirology.

[11]  J. Stone,et al.  IgG4-related disease. , 2012, The New England journal of medicine.

[12]  H. Umehara A new clinical entity: IgG4-related disease (IgG4-RD) discovered in the 21st century. , 2012, Internal medicine.

[13]  T. Furukawa,et al.  A mouse model of autoimmune pancreatitis with salivary gland involvement triggered by innate immunity via persistent exposure to avirulent bacteria , 2010, Laboratory Investigation.

[14]  O. Matsui,et al.  IgG4-related Lung and Pleural Disease: A Clinicopathologic Study of 21 Cases , 2009, The American journal of surgical pathology.

[15]  P. Perrin,et al.  Loss of the LAT adaptor converts antigen-responsive T cells into pathogenic effectors that function independently of the T cell receptor. , 2009, Immunity.

[16]  O. Matsui,et al.  Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. , 2009, Radiology.

[17]  T. Rispens,et al.  Immunoglobulin G4: an odd antibody , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  K. Uchida,et al.  The Wistar Bonn Kobori rat, a unique animal model for autoimmune pancreatitis with extrapancreatic exocrinopathy , 2008, Clinical and experimental immunology.

[19]  Y. Nakanuma,et al.  Th2 and regulatory immune reactions are increased in immunoglobin G4‐related sclerosing pancreatitis and cholangitis , 2007, Hepatology.

[20]  S. Bischoff Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data , 2007, Nature Reviews Immunology.

[21]  G. Delsol,et al.  The Th2 Lymphoproliferation Developing in LatY136F Mutant Mice Triggers Polyclonal B Cell Activation and Systemic Autoimmunity1 , 2006, The Journal of Immunology.

[22]  T. Miyazaki,et al.  A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid , 2002, Clinical and experimental immunology.

[23]  B. Malissen,et al.  Induction of T Helper Type 2 Immunity by a Point Mutation in the LAT Adaptor , 2002, Science.

[24]  T. Chiba,et al.  Experimental Immune-Mediated Pancreatitis in Neonatally Thymectomized Mice Immunized with Carbonic Anhydrase II and Lactoferrin , 2002, Laboratory Investigation.

[25]  T. Nikaido,et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.

[26]  J M Simpson,et al.  Simple method of estimating severity of pulmonary fibrosis on a numerical scale. , 1988, Journal of clinical pathology.